The effects of sitagliptin as a DPPIV inhibitor on vascular endothelial and autonomic nerve functions in patients with type II diabetes mellitus.
Not Applicable
- Conditions
- Type II diabetes mellitus
- Registration Number
- JPRN-UMIN000004236
- Lead Sponsor
- ippon Medical School Department of Medicine Division of Cardiology, Hepatology,Geriatrics and Integrated Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Type I diabetes mellitus 2) Patients receiving insulin therapy 3) Severe renal dysfunction requiring hemodialysis or peritoneal dialysis 4) Severe hepatopathy/nephropathy or heart disease that may affect the evaluation of drug safety 5) Patients who are deemed to be inappropriate by the investigator or sub-investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Flow mediated dilation (FMD)
- Secondary Outcome Measures
Name Time Method HbA1c, fasting blood glucose, autonomic nerve function